Denmark’s central bank more than doubled its growth forecast for this year as surging US sales and production at Novo Nordisk A/S boosted exports in the country’s pharmaceutical industry, according to Bloomberg.

The central bank cited the strength of Novo Nordisk’s US business and output in lifting its outlook.